End-of-day quote
Shenzhen S.E.
03:30:00 10/05/2024 am IST
5-day change
1st Jan Change
18.86
CNY
-0.42%
+9.91%
-5.42%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021
October 29, 2021 at 01:21 pm IST
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 1,083.5 million compared to CNY 770.72 million a year ago. Revenue was CNY 1,083.5 million compared to CNY 770.72 million a year ago. Net income was CNY 15.78 million compared to net loss of CNY 158.39 million a year ago. Basic earnings per share from continuing operations was CNY 0.0163 compared to basic loss per share from continuing operations of CNY 0.1639 a year ago. Diluted earnings per share from continuing operations was CNY 0.0163 compared to diluted loss per share from continuing operations of CNY 0.1639 a year ago.
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
22/04
CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
18/04
CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
26/23/26
CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd(XSEC:000766) added to S&P Global BMI Index
18/23/18
CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
20/23/20
CI
Chen Xinkai, Yu Fengchang, Han Lili, and Wei Wei completed the acquisition of a 7.24% stake in Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd from Beijing Jinshang Lianmeng Investment Management Co., Ltd.
04/23/04
CI
Chen Xinkai, Yu Fengchang, Han Lili, and Wei Wei agreed to acquire a 7.24% stake in Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd from Beijing Jinshang Lianmeng Investment Management Co., Ltd.
03/23/03
CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Approves Board Elections
14/23/14
CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
27/23/27
CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022
18/23/18
CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
28/22/28
CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022
22/22/22
CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
27/22/27
CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021
18/22/18
CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021
29/21/29
CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Half Year Ended June 30, 2021
19/21/19
CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021
27/21/27
CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Full Year Ended December 31, 2020
14/21/14
CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd(XSEC:000766) dropped from S&P Global BMI Index
21/20/21
CI
Tonghua Golden-Horse Pharmaceutical Industry Co, cancelled the acquisition of Jixi Jikuang Hospital Co., Ltd. and Shuangyashan Shuangkuang Hospital Co., Ltd. from Suzhou Industrial Park Dexin Yili Investment Center (Limited Partnership) and others.
07/20/07
CI
Tibet Dechangtai Pharmaceutical Technology Co., Ltd. signed a share transfer agreement to acquire Lhasa Yongkang Medicine Co., Ltd. from Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd for CNY 5.1 million.
06/20/06
CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2020
29/20/29
CI
Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020
19/20/19
CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the Full Year Ended December 31, 2019
28/20/28
CI
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2020
28/20/28
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
TONGHUA GOLDEN-HORSE PHARMACEUTICAL INDUSTRY CO,LTD is a China-based company principally engaged in the manufacture and distribution of pharmaceutical products. The Company's main products consist of Chinese patent drugs, chemical drugs and bulk drugs, among others. The Companyâs products are used in anti-tumor, microbial, digestive system, skeletal and muscle system, gynecology, nervous system and other areas. The Company distributes its products mainly in domestic market.
More about the company
1st Jan change
Capi.
-5.42% 2.52B +30.38% 684B +26.51% 568B -4.36% 361B +19.30% 329B +3.73% 284B +16.70% 240B +8.78% 208B -7.93% 200B +7.68% 166B
Other Pharmaceuticals
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1